Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Smith & Nephew SNATS, Inc. SNN

Healthcare  —  Medical Devices
26.91 0.23 0.86% as of 25 Sep
Market cap
$11.2B
P/E
32.8×
Cash Flow Champion (3y) Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Smith & Nephew SNATS, Inc. (SNN) Business Profile

Updated before January 2025

Company Overview

Smith & Nephew SNATS, Inc. (SNN) is a global medical technology company that specializes in advanced medical devices for healthcare professionals. Founded in 1856 in Hull, England, by Thomas James Smith, the company initially focused on pharmaceutical products. Over the years, Smith & Nephew evolved into a leading provider of medical technologies, with a strong emphasis on innovation and patient care. Today, the company operates in over 100 countries and is headquartered in Watford, United Kingdom. Key leadership includes Deepak Nath, who serves as the Chief Executive Officer, and other senior executives who drive the company’s strategic vision and operational excellence.

Core Business Segments

Smith & Nephew operates across three primary business segments, offering a wide range of products and services:

1. Orthopaedics

This segment focuses on joint replacement systems and trauma products. Key offerings include:

  • Hip and Knee Implants: Advanced solutions for joint replacement surgeries, such as the LEGION™ Total Knee System and the POLAR3™ Total Hip Solution.
  • Trauma Products: Devices for fracture fixation, including the EVOS™ Small and Large Plating Systems.

2. Sports Medicine & ENT (Ear, Nose, and Throat)

This segment provides solutions for minimally invasive surgery and ENT procedures. Key offerings include:

  • Arthroscopy Products: Tools for joint repair and reconstruction, such as the FAST-FIX™ Meniscal Repair System.
  • ENT Devices: Products like COBLATION™ technology for tonsil and adenoid removal.

3. Advanced Wound Management

This segment addresses wound care needs with innovative products. Key offerings include:

  • Negative Pressure Wound Therapy (NPWT): Systems like PICO™ for managing complex wounds.
  • Advanced Dressings: ALLEVYN™ foam dressings for effective wound healing.

Business Model

Smith & Nephew’s business model integrates product innovation, customer-centric services, and strategic partnerships to generate revenue. The company invests heavily in research and development (R&D) to create cutting-edge medical technologies. Revenue streams primarily come from the sale of medical devices, licensing agreements, and service contracts. SNN also collaborates with healthcare providers to deliver training and support, ensuring optimal use of its products.

Strategic Direction

Smith & Nephew aims to drive growth through innovation, sustainability, and market expansion. Key strategic priorities include:

  • Innovation: Developing next-generation medical devices and leveraging digital technologies like robotics and AI.
  • Sustainability: Committing to environmental goals, such as reducing carbon emissions and promoting sustainable manufacturing practices.
  • Market Expansion: Entering emerging markets and expanding its footprint in existing regions.

Competitive Landscape

Smith & Nephew faces competition from several global and regional players in the medical technology sector. Key competitors include:

  • Johnson & Johnson: A leader in orthopaedics and wound care.
  • Stryker Corporation: Known for its advanced surgical and orthopaedic products.
  • Zimmer Biomet: Specializes in joint replacement and musculoskeletal solutions.
  • Medtronic: Competes in minimally invasive surgery and ENT devices.

Risk Factors

Smith & Nephew faces several risks that could impact its operations and financial performance:

  • Market Dependence: Reliance on specific product categories, such as orthopaedics, makes the company vulnerable to market fluctuations.
  • Supply Chain Disruptions: Global supply chain issues, including raw material shortages, could affect production.
  • Regulatory Challenges: Compliance with stringent healthcare regulations in different countries poses a risk.
  • Competition: Intense competition may pressure pricing and market share.

Recent Developments

Smith & Nephew has recently introduced several innovations and strategic initiatives:

  • New Product Launches: The introduction of the CORI™ Surgical System, a handheld robotic platform for knee replacement surgeries.
  • Sustainability Initiatives: Commitment to achieving net-zero carbon emissions by 2045.
  • Global Expansion: Strengthening its presence in Asia-Pacific and Latin America through strategic partnerships and acquisitions.

Investment Considerations

Strengths:

  • Strong brand reputation and global presence.
  • Robust R&D capabilities driving innovation.
  • Diversified product portfolio across multiple healthcare segments.

Risks:

  • Exposure to regulatory and compliance risks.
  • Dependence on specific markets and product categories.
  • Vulnerability to macroeconomic factors, such as currency fluctuations.

Conclusion

Smith & Nephew SNATS, Inc. is a leading player in the medical technology industry, known for its innovative products and commitment to patient care. With a strong focus on sustainability and market expansion, the company is well-positioned for future growth. However, investors should consider the risks associated with regulatory challenges and market dependence. Overall, SNN remains a compelling choice for those seeking exposure to the healthcare sector.